Next Article in Journal
The Implications of Community Forest Income on Social and Environmental Sustainability
Next Article in Special Issue
Cellulolytic Bacillus Strain: Production Optimization Using Wheat Bran under Solid-State Fermentation and Investigation of Its Probiotic Potential
Previous Article in Journal
Different Cropping Patterns to Restore Saline-Alkali Soils in Northeast China Affect the Abundance of Functional Genes in the Soil Nitrogen Cycle
Previous Article in Special Issue
An Experimental Comparison of the Performance of Various Evacuated Tube Solar Collector Designs
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Numerical Analysis of Sulfamerazine Solubility in Acetonitrile + 1-Propanol Cosolvent Mixtures at Different Temperatures

by
Claudia Patricia Ortiz
1,
Rossember Edén Cardenas-Torres
2,
Mauricio Herrera
3 and
Daniel Ricardo Delgado
3,*
1
Programa de Administración en Seguridad y Salud en el Trabajo, Grupo de Investigación en Seguridad y Salud en el Trabajo, Corporación Universitaria Minuto de Dios-UNIMINUTO, Neiva 410001, Colombia
2
Grupo de Fisicoquímica y Análisis Matemático, Facultad de Ciencias y Humanidades, Fundación Universidad de América, Bogotá 111221, Colombia
3
Programa de Ingeniería Civil, Grupo de Investigación de Ingenierías UCC-Neiva, Facultad de Ingeniería, Sede Neiva, Universidad Cooperativa de Colombia, Neiva 410001, Colombia
*
Author to whom correspondence should be addressed.
Sustainability 2023, 15(8), 6596; https://doi.org/10.3390/su15086596
Submission received: 7 March 2023 / Revised: 29 March 2023 / Accepted: 29 March 2023 / Published: 13 April 2023

Abstract

:
The current challenges of the pharmaceutical industry regarding the environmental impact caused by its waste have led to the design and development of more efficient industrial processes. In this context, solubility studies are at the core of different processes, such as formulation, preformulation, synthesis, purification, recrystallization, quantification, and quality control. This research evaluates the solubility of sulfamerazine (SMR) in acetonitrile + 1-propanol cosolvent mixtures at nine temperature levels with UV/vis spectrophotometry using the vial-shake method. According to the analysis of the solid phase in equilibrium using differential scanning calorimetry, there were no polymorphic changes. The minimal solubility of SMR was reached in 1-propanol at 278.15 K, and the maximal solubility in acetonitrile at 313.15 K. In all cases, the process was endothermic and dependent on the cosolvent composition, and the solution enthalpy drove the solution process. The solubility data were well correlated with the van’t Hoff, Yalkowsky–Roseman–van’t Hoff, Apelblat, Buchowski–Ksiazczak λh, Yaws, NRTL, Wilson, and modified Wilson models, with the YR model being one of the most attractive because it presented an excellent prediction percentage from four sets of experimental data. The solution process of SMR in acetonitrile + 1-propanol cosolvent mixtures depends on the affinity of SMR for acetonitrile and temperature increase.

1. Introduction

Sulfonamides were some of the first drugs used effectively in infection control. They significantly reduced morbidity and mortality from conditions caused by Gram-positive and -negative bacteria [1,2]. Due to their toxic nature and the introduction of safer antibiotics such as penicillin, their use decreased [3]. However, the uncontrolled use of antibiotics has led to bacterial resistance to most of these therapeutic agents [4]. Due to the above, the use of sulfonamides has increased again in human and veterinary therapy [5], which, in turn, has led to major environmental concerns [6,7,8].
Sulfonamides act by inhibiting the synthesis of dihydrofolic acid, as they are competitive antagonists of para-aminobenzoic acid (PABA), decreasing the synthesis of nucleotides and bacterial DNA [9,10].
Sulfamerazine (SMR; Figure 1) is used in the treatment of pathologies caused by bacteria, such as bronchitis, prostatitis, and urinary tract infections [11,12].
One of the major challenges when developing drug formulations whose active pharmaceutical ingredient (API) is SMR is the low solubility of the drug in aqueous systems; therefore, studies in cosolvent systems are highly relevant [13,14]. In addition, SMR is among the most widely used sulfonamides in the design of pharmaceutical forms (FPs) for veterinary use, and due to the increase in bacterial resistance to first-line antibiotics meant for humans, its use in the development of FP for human therapy has also increased. The solubility of SMR was studied in several cosolvent mixtures of pharmaceutical interest, such as water and methanol [15], water and ethanol [16], water and 1-propanol [17], acetonitrile and methanol [11], ethylene glycol and water [18], acetonitrile and water [12], and propylene glycol and water [19]. Nevertheless, it is important to conduct new studies in order to contribute to the understanding of the possible mechanisms of the SMR solution process.
Mathematical modeling is another important line of research in the field of solubility. In this area, the developed strategies focused on reducing experimental tests to a minimum, which generally optimizes processes and reduces the volume of polluting waste [20]. Some of the most widely used models are van’t Hoff [21], Apelblat [22], Buchowski–Ksiazaczak λh [23], and Yaws [24]. Each of these allows for the calculation of solubility as a function of temperature, which is very convenient when evaluating the solubility of an API at a different temperature from that determined experimentally. Other models, such as Yalkowsky–Roseman [25], modified Wilson [26], Jouyban–Acree [14], Wilson [27], and nonrandom two-liquid (NRTL) [28] correlate API solubility as a function of cosolvent mixtures, allowing for solubility to be calculated over ranges of polarity or cosolvent composition specific.
The aim of this research is to assess the thermodynamics of the SMR solution process in acetonitrile and 1-propanol cosolvent mixtures at nine temperature levels (278.15 up to 318.15 K). Acetonitrile (MeCN) and 1-propanol (1-PrOH) are both widely used solvents in industry, especially in crystallization and qualification processes. In addition, experimental data were correlated with different mathematical models used in the industry.

2. Materials and Methods

2.1. Reagents

Some characteristics of the reagents used in this research are shown in Table 1.

2.2. Solubility Determination

To begin with, 19 cosolvent mixtures {MeCN (1) + 1-PrOH (2)} were prepared by varying 0.05 of their composition in an MeCN mass fraction. Once the cosolvent mixtures were prepared, enough SMR was added to obtain a saturated solution at each of the 9 study temperatures (278.15 K up to 318.15 K).
The measurement of the solubility in each mixture was performed according to the shake-flask method proposed by Higuchi and Connors [29], which consists of four phases: (1) saturation, (2) phase separation (filtration), (3) quantification (UV/Vis), and (4) solid phase analysis. This method is sufficiently described in some works conducted and published by the research group [20,30].

2.3. Mathematical Processing of Data

Each solubility value is presented as the result of the average of three measurements with its standard deviation, expressed by applying the 3–30 criterion [31]. These values were used to draw the van’t Hoff plots, which were fitted by the least squares method while applying uncertainty propagation methods using the software R version 4.2.3 (Shortstop Beagle).

3. Results

3.1. Solubility (x3) of Sulfamerazine (3) in Some Cosolvent Mixtures {MeCN (1) + n-PrOH (2)}

The solubility data for SMR in cosolvent mixtures {MeCN (1) + 1-PrOH (2)} are reported in Table 2. In all cases, the solubility of SMR increases with increasing temperature and increasing MeCN mass fraction, reaching its minimum solubility in neat 1-PrOH at 278.15 K, and the maximum solubility in neat MeCN at 318.15 K (Figure 2).
Usually, one of the most influential factors in the solubility of a drug is the relationship between the solubility parameters ( δ ) of the drug and the solvent. In this case, the δ from the MeCN and the 1-PrOH are similar ( δ MeCN = 24.8 MPa 1 / 2 and δ 1 - PrOH = 24.9 MPa 1 / 2 [20,32,33]) and, apparently, the solubility changes are not related to the δ mix from the cosolvent mixture. However, when considering the Kamlet–Taft acidity scale α [34], a relation can be deduced by increasing SMR solubility and increasing MeCN, since MeCN is less acidic than 1-PrOH ( α MeCN = 0.29 ± 0.06 ; α 1 - PrOH = 0.776 ± 0.013 ) and SMR is acidic [35].
A further factor that can affect the solubility of drugs is polymorphic changes, so it is important to analyze the solid phase in equilibrium with the cosolvent system. Table 3 shows the enthalpy and melting temperatures from the original sample and the solid phases in equilibrium with neat 1-PrOH, w 1 = 0.5 , and neat MeCN determined by DSC (Figure 3). It is observed that all four samples analyzed have similar enthalpy and melting temperature values, so it can be concluded that there are no polymorphic changes. Likewise, the values obtained in this research are consistent with those reported by other authors.

3.2. Thermodynamic Functions of Solution

From the experimental solubility data (Table 2), the thermodynamic solution functions were calculated according to Equations (1)–(5), proposed by the Gibbs–van’t Hoff–Krug model [42,43].
Δ soln H ° = R ln x 3 T 1 T hm 1 p
Δ soln G ° = R T hm . intercept
Δ soln S ° = Δ soln H ° Δ soln G ° T hm 1
ζ H = | Δ soln H ° | ( | T Δ soln S ° | + | Δ soln S ° | ) 1
ζ T S = 1 ζ H
where Δ soln H ° (in kJ·mol−1), Δ soln G ° (en kJ·mol−1), and Δ soln S ° (in kJ·mol−1· T hm 1 ) are the thermodynamic functions: enthalpy, Gibbs energy, and entropy of solution. T is the study temperature (in K), T hm is the harmonic temperature (in K), R is the gas constant (kJ·mol−1·K−1), and ζ H and ζ T S are the enthalpic and entropic contributions to the solution process.
T hm is calculated through Equation (6).
T hm = n i = 1 n 1 T i
where n is the number of study temperatures ( n = 9 ) and T is the study temperatures (278.15, 283.15, 288.15, 293.15, 298.15, 303.15, 308.15, 313.15, and 318.15 K); therefore, T hm is equal to 297.6 K.
Then, from each equation ( y = m x + b ) in the van’t Hoff plot (Figure 4), Δ soln H ° (from the slope values m) and Δ soln G ° (from the intercept values b) were calculated.
The thermodynamic functions of the solution are presented in Table 4, and Δ soln G ° is positive in all cases and decreases with increasing MeCN concentration as a consequence of increasing solubility ( x 3 ). Concerning the Δ soln H ° , it is also positive, indicating an endothermic solution process and, similar to Gibbs energy, the enthalpy of the solution decreases as the concentration of MeCN increases. This indicates an increase in molecular interactions, which agrees with the increase in SMR solubility. Regarding the Δ soln S ° , it is positive as well, favoring the solution process, and it increases with increasing MeCN concentration.
When analyzing the contribution of enthalpy and entropy to the solution process using Equations (4) and (5) (Table 4), the ζ H values are greater than ζ T S in all cases, indicating that the solution process is driven by the enthalpy of the solution. This analysis was verified using the Perlovich graphical method (Figure 5), where all values were found in sector I ( Δ soln H ° > T Δ soln S ° [44,45]), validating that the solution process is driven by enthalpy.

3.3. Thermodynamic Functions of Mixing

The solution process involves the molecular rearrangement of the solute and solvent (Figure 6); hence, there must be a diffusion process of the solute and solvent molecules, which involves a hypothetical melting process for the solute.
Therefore, the solution process thermodynamics can be described as follows:
Δ soln f ° 297.6 = Δ m f ° 297.6 + Δ mix f ° 297.6
where f represents the thermodynamic functions (Gibbs energy, enthalpy, and entropy), and the subscripts soln, m, and mix indicate the solution, melting, and mixing, respectively.
In this research, the thermodynamic fusion ( Δ m f ° 297.6 ) functions were replaced by the thermodynamic functions of the ideal ( Δ id f ° 297.6 ) process, as described by Mora and Martínez [46]
Δ mix f ° 297.6 = Δ sol f ° 297.6 Δ id f ° 297.6
In Table 5, the thermodynamic functions of SMR mixing in {MeCN (1) + 1-PrOH (2)} are presented. The Gibb energy of mixing is positive in all cases, indicating a favoring of the mixing process over the solution process. The enthalpy of mixing is positive and decreases with increasing MeCN concentration in the solution; hence, it can be assumed that cavity formation (Figure 6) involves less energy in MeCN-rich mixtures. The enthalpy of mixing is positive in all cases, indicating an entropic favoring of mixing to the solution process, and it increases with increasing MeCN mass fraction.
By analyzing the enthalpic and entropic contributions to the mixing process using the Perlovich plot (Figure 7), the mixing process is driven by the entropy of mixing. When plotting the mixing entropy values as a function of mixing enthalpy, all points were in sector II: ( Δ soln H ° < T Δ soln S ° ; | T Δ soln S ° | > | Δ soln H ° | [44,45]).

3.4. Enthalpy–Entropy Compensation Analysis

In the solution process, enthalpy changes occur that are compensated by entropy changes as a consequence of non-covalent interactions between the solute and the solvent, promoting the solution process to take place [47]. Plotting this compensation yields linear trends that indicate which thermodynamic function is driving the process [48,49].
Sharp suggests that changes in T Δ soln G ° with linear relations between T Δ soln S ° and Δ soln H ° indicate strongly compensated processes [48].
Usually, the enthalpy–entropy compensation can be evaluated by plotting Δ soln H ° vs. Δ soln G ° , with negative slopes indicating entropic compensation and positive slopes indicating enthalpic compensation to the solution process [50,51].
Thus, according to Figure 8, the solution process is driven by the solution enthalpy since the slope in the plot is positive.

3.5. Mathematical Assessment of Solubility

The experimental solubility of SMR in the system {MeCN (1) + 1-PrOH (2)} was correlated with some models used in the pharmaceutical industry.
Accordingly, the models evaluated were van’t Hoff (Equation (9)), Yalkowsky–Roseman–van’t Hoff (Equation (10)), Apelblat (Equation (11)), Buchowski–Ksiazczak λh (Equation (12)), Yaws (Equation (13)), NRTL (Equation (14)), Wilson (Equation (15)), and modified Wilson (Equation (15)). The models van’t Hoff, Apelblat, Buchowski–Ksiazczak λ h, and Yaws correlated the solubility as a function of the temperature, and the NRTL, Wilson, and modified Wilson models correlated the solubility as a function of solvent or cosolvent mixtures.
A particularly versatile model was the combined Yalkowsky–Roseman–van’t Hoff (Equation (10)), since it allowed calculating, simultaneously, the solubility of SMR at different temperatures and MeCN mass fractions. In addition, the model was developed from four sets of experimental data (solubility of SMR in MeCN and 1-PrOH at 278.18 and 318.15 K, respectively).
ln x 3 = A + B T
ln x 3 , 1 + 2 = w 1 A 1 + B 1 T + ( 1 w 1 ) A 2 + B 2 T
ln x 3 = A + B T + C ln T
ln 1 + λ ( 1 x 3 ) x 3 = λ h 1 T 1 T m
ln x 3 = A + B T + C T 2
ln γ 3 = x 2 τ 23 G 23 + x 1 τ 13 G 13 x 3 + x 2 G 23 + x 3 G 13 x 3 ( x 2 τ 23 G 23 + x 1 τ 13 G 13 ) ( x 3 + x 2 G 23 + x 3 G 13 ) 2 + x 2 G 32 x 3 G 32 + x 2 + x 1 G 12 τ 32 x 3 τ 32 G 32 + x 1 τ 12 G 12 x 3 G 32 + x 2 + x 1 G 12 + x 1 G 31 x 3 G 31 + x 2 G 21 + x 1 τ 31 x 3 τ 31 G 31 + x 2 τ 21 G 21 x 3 G 31 + x 2 G 21 + x 1
ln γ 3 = 1 ln ( x 3 + x 2 Λ 32 + x 1 Λ 31 )   x 3 x 3 + x 2 Λ 32 + x 1 Λ 31   x 2 Λ 23 x 3 Λ 23 + x 2 + x 1 Λ 21 x 1 Λ 13 x 3 Λ 13 + x 2 Λ 12 + x 1
ln x 3 , 1 + 2 = 1 w 1 1 ln x 3 , 1 w 1 + w 2 λ 12 w 2 1 ln x 3 , 2 w 2 + w 1 λ 21
In order to evaluate the accuracy of each model, the mean percentage deviation (MPD) was used (Equation (17)).
M P D = 100 N i = 1 N x 3 x 3 c x 3
where N is the number of solubility data points, and x 3 and x 3 c represent the experimentally measured and calculated solubility, respectively [14].
The models were developed with Python, and the functions of each model are fitted by nonlinear least squares using the library scipy.optimize.curve_fit. In order to validate the model fit, the experimental data were partitioned into training data and test data using the library sklearn.model_selection. The fitting was conducted with 60% of the experimental data taken randomly, and the testing or validation was conducted with the remaining experimental data.
The correlation statistics of the models are presented in Table 6. In all cases, the correlation coefficients are approximately 1.0, the F values are high, the critical F values are low, and the p values are < 0.001 , indicating that the correlation and model constants are significant.
Moreover, Figure 9 shows the correlation between the experimental data and those calculated with each model. Then, the lowest accuracy is reached with the van’t Hoff and Yalkowsky–Roseman–van’t Hoff models (MPD: 5.53 and 6.65, respectively). However, it is noteworthy that for the Yalkowsky–Roseman–van’t Hoff model, only 2.1% of the experimental data (four data sets) were used for fitting, which makes it an excellent predictive model. In relation to the other models, all showed an excellent correlation with MPD <3.0. Overall, the MPD for all models is within a reasonable range, where an error of 30% is acceptable for correlating solubility data in the pharmaceutical field [52,53].
In general, models correlating solubility as a function of temperature, such as van’t Hoff, Apelblat, Buchowski–Ksiazczak, and Yaws, present better correlation coefficients [54,55] compared to those reported in this work. However, the deviation from the logarithm linearity of the SMR solubility in mixtures rich in MeCN and neat MeCN leads to small dispersions in the models (Figure 9).
Regarding the NRTL, Wilson, and modified Wilson models, they usually present high correlations between experimental and calculated data [56]. In this case, the correlation coefficients were equal to 1.000 (Table 6), demonstrating the versatility of these models.
The parameters of the equations of each of the evaluated models and the MPD are presented in Tables S1–S8 (Supplementary Materials).

4. Conclusions

The solution process of SMR in cosolvent mixtures {MeCN (1) + 1-PrOH (2)} is endothermic and depends on the cosolvent composition. Due to the acidic character of SMR, it reaches its maximum solubility in neat MeCN possibly because it is less acidic than 1-PrOH.
Concerning the thermodynamic characterization, the Gibbs energy of the solution decreases with increasing MeCN in the cosolvent mixture as a consequence of increasing solubility. The enthalpy is positive, which disfavors the solution process; however, an increase in entropy is observed, which is positive in all cases, favoring the solution process. On the other hand, the thermodynamic mixing functions indicate that the mixing process favors the overall solution process.
Finally, regarding the mathematical modeling, the proposed models presented a good accuracy, highlighting the combined Yalkowsky–Roseman–van’t Hoff model, which presented an MPD lower than 6.65 using only 2.1% of the experimental data when developing the model.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/su15086596/s1, The parameters of the equations of each of the evaluated models and the MPD are presented in Tables S1–S8.

Author Contributions

Conceptualization, C.P.O. and D.R.D.; methodology, D.R.D. and C.P.O.; software, R.E.C.-T.; validation, C.P.O. and D.R.D.; formal analysis, C.P.O.; investigation, M.H. and C.P.O.; resources, M.H. and D.R.D.; data curation, D.R.D.; writing—original draft preparation, C.P.O.; writing—review and editing, M.H., C.P.O. and D.R.D.; visualization, C.P.O.; supervision, D.R.D.; project administration, D.R.D.; and funding acquisition, D.R.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Universidad Cooperativa de Colombia grant number INV3171.

Institutional Review Board Statement

Not applicable for studies not involving humans or animals.

Informed Consent Statement

Not applicable for studies not involving humans.

Data Availability Statement

Data are contained within the article.

Acknowledgments

We thank the National Directorate of Research and National Committee for Research Development of the Universidad Cooperativa de Colombia for the financial support of the Project “Análisis matemático y termodinámico de la solubilidad algunas sustancias antimicrobianas de uso industrial en mezclas cosolventes” with code INV3171. We also thank the Universidad Cooperativa de Colombia, Sede Neiva, for facilitating the laboratories and equipment used.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

The following abbreviations are used in this manuscript:
1-PrOH1-Propanol
C P Molar heat capacity
CASChemical Abstracts Service Registry Number
DSCDifferential scanning calorimetry
gGrams
GGibbs Energy
GCGas chromatography
HEnthalpy
hmHarmonic mean
HPLCHigh-performance liquid chromatography
idIdeal
JJoule
KKelvin
kKilo
mMelting
MeCNAcetonitrile
mixMixing
RGas constant
SEntropy
solSolution
SMRSulfamerazine
TTemperature
T hm Harmonic temperature
UVUltraviolet
wMass fraction
xMole fraction
δ Solubility parameter

References

  1. Stokstad, E.L.R.; Jukes, T.H. Sulfonamides and Folic Acid Antagonists: A Historical Review. J. Nutr. 1987, 117, 1335–1341. [Google Scholar] [CrossRef]
  2. Beale, J.M.J. Anti-infective Agents. In Organic Medicinal and Pharmaceutical Chemistry; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2011; Chapter 6; pp. 228–238. [Google Scholar]
  3. Forgacs, P.; Wengenack, N.L.; Hall, L.; Zimmerman, S.K.; Silverman, M.L.; Roberts, G.D. Tuberculosis and Trimethoprim-Sulfamethoxazole. Antimicrob. Agents Chemother. 2009, 53, 4789–4793. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Harrower, J.; McNaughtan, M.; Hunter, C.; Hough, R.; Zhang, Z.; Helwig, K. Chemical Fate and Partitioning Behavior of Antibiotics in the Aquatic Environment—A Review. Environ. Toxicol. Chem. 2021, 40, 3275–3298. [Google Scholar] [CrossRef] [PubMed]
  5. Hruska, K.; Franek, M. Sulfonamides in the environment: A review and a case report. Vet. Med. 2012, 57, 1–35. [Google Scholar] [CrossRef] [Green Version]
  6. Gao, Q.; Deng, W.; Gao, Z.; Li, M.; Liu, W.; Wang, X.; Zhu, F. Effect of sulfonamide pollution on the growth of manure management candidate Hermetia illucens. PLoS ONE 2019, 14, 1–12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Kergoat, L.; Besse-Hoggan, P.; Leremboure, M.; Beguet, J.; Devers, M.; Martin-Laurent, F.; Masson, M.; Morin, S.; Roinat, A.; Pesce, S.; et al. Environmental Concentrations of Sulfonamides Can Alter Bacterial Structure and Induce Diatom Deformities in Freshwater Biofilm Communities. Front. Microbiol. 2021, 12, 1–12. [Google Scholar] [CrossRef] [PubMed]
  8. Chen, J.; Tong, T.; Jiang, X.; Xie, S. Biodegradation of sulfonamides in both oxic and anoxic zones of vertical flow constructed wetland and the potential degraders. Environ. Pollut. 2020, 265, 115040. [Google Scholar] [CrossRef] [PubMed]
  9. Sarkar, D. Sulfonamides: An Overview; Chemistry Research and Applications Series; Nova Science Publishers, Incorporated: Hauppauge, NY, USA, 2021. [Google Scholar]
  10. Farrukh, M.; Ahmad, S. Synthesis, Characterization and Applications of Sulfonamides; Lap Lambert Academic Publishing GmbH KG: Saarbruecken, Germany, 2011. [Google Scholar]
  11. Cárdenas-Torres, R.E.; Ortiz, C.P.; Acree, W.E.; Jouyban, A.; Martínez, F.; Delgado, D.R. Thermodynamic study and preferential solvation of sulfamerazine in acetonitrile + methanol cosolvent mixtures at different temperatures. J. Mol. Liq. 2022, 349, 118172. [Google Scholar] [CrossRef]
  12. Blanco-Márquez, J.H.; Ortiz, C.P.; Cerquera, N.E.; Martínez, F.; Jouyban, A.; Delgado, D.R. Thermodynamic analysis of the solubility and preferential solvation of sulfamerazine in (acetonitrile + water) cosolvent mixtures at different temperatures. J. Mol. Liq. 2019, 293, 111507. [Google Scholar] [CrossRef]
  13. Rubino, J.T. Cosolvents and Cosolvency. In Encyclopedia of Pharmaceutical Science and Technology, 4th ed.; CRC Press: Boca Raton, FL, USA, 2015; Volume 6, pp. 375–398. [Google Scholar]
  14. Jouyban, A. Review of the cosolvency models for predicting solubility of drugs in water-cosolvent mixtures. J. Pharm. Pharm. Sci. 2008, 11, 32–58. [Google Scholar] [CrossRef] [Green Version]
  15. Delgado, D.R.; Martínez, F. Solution thermodynamics and preferential solvation of sulfamerazine in methanol + water mixtures. J. Solut. Chem. 2015, 44, 360–377. [Google Scholar] [CrossRef]
  16. Delgado, D.R.; Martínez, F. Solubility and solution thermodynamics of sulfamerazine and sulfamethazine in some ethanol + water mixtures. Fluid Phase Equilib. 2013, 360, 88–96. [Google Scholar] [CrossRef]
  17. Delgado, D.R.; Martínez, F. Solubility and solution thermodynamics of some sulfonamides in 1-propanol + water mixtures. J. Solut. Chem. 2014, 43, 836–885. [Google Scholar] [CrossRef]
  18. Vargas-Santana, M.S.; Cruz-González, A.M.; Ortiz, C.P.; Delgado, D.R.; Martínez, F.; Ángeles Peña, M.; Acree, W.E.; Jouyban, A. Solubility of sulfamerazine in (ethylene glycol + water) mixtures: Measurement, correlation, dissolution thermodynamics and preferential solvation. J. Mol. Liq. 2021, 337, 116330. [Google Scholar] [CrossRef]
  19. del Mar Muñoz, M.; Delgado, D.R.; Ángeles Peña, M.; Jouyban, A.; Martínez, F. Solubility and preferential solvation of sulfadiazine, sulfamerazine and sulfamethazine in propylene glycol + water mixtures at 298.15K. J. Mol. Liq. 2015, 204, 132–136. [Google Scholar] [CrossRef]
  20. Trujillo-Trujillo, C.F.; Angarita-Reina, F.; Herrera, M.; Ortiz, C.P.; Cardenas-Torres, R.E.; Martinez, F.; Delgado, D.R. Thermodynamic Analysis of the Solubility of Sulfadiazine in (Acetonitrile 1-Propanol) Cosolvent Mixtures from 278.15 K to 318.15 K. Liquids 2023, 3, 2. [Google Scholar] [CrossRef]
  21. Lin, A.Y.; Cheng, K.T.; Chen, S.C.; Tsui, H.W. Effect of solvent composition on the van’t Hoff enthalpic curve using amylose 3,5-dichlorophenylcarbamate–based sorbent. J. Chromatogr. A 2017, 1515, 179–186. [Google Scholar] [CrossRef]
  22. Apelblat, A.; Manzurola, E. Solubilities ofo-acetylsalicylic, 4-aminosalicylic, 3,5-dinitrosalicylic, andp-toluic acid, and magnesium-DL-aspartate in water from T = (278 to 348) K. J. Chem. Thermodyn. 1999, 31, 85–91. [Google Scholar] [CrossRef]
  23. Ksiazczak, A.; Kosinski, J.J. Vapour pressure of binary, three-phase (S-L-V) systems and solubility. Fluid Phase Equilib. 1988, 44, 211–236. [Google Scholar] [CrossRef]
  24. Tinoco, L.E.; Galindres, D.M.; Osorio, J.; Cárdenas, R.E. Predicción de la solubilidad de sulfamerazina y sulfametazina en algunas mezclas cosolventes utilizando modelos de solución no ideales. Rev. Colomb. Cienc. Químico-Farm. 2021, 50, 292–313. [Google Scholar]
  25. Vargas-Santana, M.S.; Cruz-González, A.M.; Cerquera, N.E.; Escobar Rodriguez, A.S.; Cardenas, R.E.; Calderón-Losada, O.; Ortiz, C.P.; Delgado, D.R. Método extendido de Hildebrand y modelo de Yalkowsky- Roseman en la estimación de la solubilidad de sulfadiazina y sulfametazina en algunas mezclas etilenglicol (1) + agua (2) a varias temperaturas. Rev. Colomb. Cienc. Químico-Farm. 2022, 50, 812–836. [Google Scholar]
  26. Jouyban-Gharamaleki, A. The Modified Wilson Model and Predicting Drug Solubility in Water-Cosolvent Mixtures. Chem. Pharm. Bull. 1998, 46, 1058–1061. [Google Scholar] [CrossRef] [Green Version]
  27. Wilson, G.M. Vapor-Liquid Equilibrium. XI. A New Expression for the Excess Free Energy of Mixing. J. Am. Chem. Soc. 1964, 86, 127–130. [Google Scholar] [CrossRef]
  28. Prausnitz, J.M.; Lichtenthaler, R.N.; Edmundo, G. Molecular Thermodynamics of Fluid-Phase Equilibria; Prentice Hall PTR: Upper Saddle River, NJ, USA, 1999. [Google Scholar]
  29. Dittert, L.W.; Higuchi, T.; Reese, D.R. Phase solubility technique in studying the formation of complex salts of triamterene. J. Pharm. Sci. 1964, 53, 1325–1328. [Google Scholar] [CrossRef]
  30. Torres-Cardozo, A.; Cerquera, N.E.; Ortiz, C.P.; Osorio-Gallego, J.; Cardenas-Torres, R.E.; Angarita-Reina, F.; Martinez, F.; Delgado, D.R. Thermodynamic analysis of the solubility of progesterone in 1-octanol + ethanol cosolvent mixtures at different temperatures. Alex. Eng. J. 2023, 64, 219–235. [Google Scholar] [CrossRef]
  31. Shoemaker, D.; Garland, C.; Steinfeld, J. Experiments in Physical Chemistry; McGraw-Hill: New York, NY, USA, 1974. [Google Scholar]
  32. Barton, A.F.M. Solubility parameters. Chem. Rev. 1975, 75, 731–753. [Google Scholar] [CrossRef]
  33. Barton, A. CRC Handbook of Solubility Parameters and Other Cohesion Parameters, 2nd ed.; CRC Press: Boca Raton, FL, USA, 2017. [Google Scholar]
  34. Taft, R.W.; Kamlet, M.J. The solvatochromic comparison method. 2. The .alpha.-scale of solvent hydrogen-bond donor (HBD) acidities. J. Am. Chem. Soc. 1976, 98, 2886–2894. [Google Scholar] [CrossRef]
  35. Remko, M.; von der Lieth, C.W. Theoretical study of gas-phase acidity, pKa, lipophilicity, and solubility of some biologically active sulfonamides. Bioorganic Med. Chem. 2004, 12, 5395–5403. [Google Scholar] [CrossRef]
  36. Sunwoo, C.; Eisen, H. Solubility Parameter of Selected Sulfonamides. J. Pharm. Sci. 1971, 60, 238–244. [Google Scholar] [CrossRef]
  37. Lee, M.J.; Seo, D.Y.; Wang, I.C.; Chun, N.H.; Lee, H.E.; Jeong, M.Y.; Kim, W.S.; Choi, G.J. Quantitative In-Line Monitoring of Solvent-Mediated Polymorphic Transformation of Sulfamerazine by Near-Infrared Spectroscopy. J. Pharm. Sci. 2012, 101, 1578–1586. [Google Scholar] [CrossRef]
  38. Martínez, F.; Gómez, A. Estimation of the Solubility of Sulfonamides in Aqueous Media from Partition Coefficients and Entropies of Fusion. Phys. Chem. Liq. 2002, 40, 411–420. [Google Scholar] [CrossRef]
  39. Khattab, F.I. Thermal analysis of pharmaceutical compounds. V. The use of differential scanning calorimetry in the analysis of certain pharmaceuticals. Thermochim. Acta 1983, 61, 253–268. [Google Scholar] [CrossRef]
  40. Delombaerde, D. Co-Amorphous Drug Formulations: Carbamazepine, Mefenamic Acid and Sulfamerazine. Master’s Thesis, Ghent University, Ghent, Belgium, 2021. [Google Scholar]
  41. Aloisio, C.; de Oliveira, A.G.; Longhi, M. Solubility and release modulation effect of sulfamerazine ternary complexes with cyclodextrins and meglumine. J. Pharm. Biomed. Anal. 2014, 100, 64–73. [Google Scholar] [CrossRef] [PubMed]
  42. Krug, R.R.; Hunter, W.G.; Grieger, R.A. Enthalpy-entropy compensation. 1. Some fundamental statistical problems associated with the analysis of van’t Hoff and Arrhenius data. J. Phys. Chem. 1976, 80, 2335–2341. [Google Scholar] [CrossRef]
  43. Krug, R.R.; Hunter, W.G.; Grieger, R.A. Enthalpy-entropy compensation. 2. Separation of the chemical from the statistical effect. J. Phys. Chem. 1976, 80, 2341–2351. [Google Scholar] [CrossRef]
  44. Perlovich, G.L.; Tkachev, V.V.; Strakhova, N.N.; Kazachenko, V.P.; Volkova, T.V.; Surov, O.V.; Schaper, K.; Raevsky, O.A. Thermodynamic and structural aspects of sulfonamide crystals and solutions. J. Pharm. Sci. 2009, 98, 4738–4755. [Google Scholar] [CrossRef]
  45. Perlovich, G.L.; Strakhova, N.N.; Kazachenko, V.P.; Volkova, T.V.; Tkachev, V.V.; Schaper, K.J.; Raevsky, O.A. Sulfonamides as a subject to study molecular interactions in crystals and solutions: Sublimation, solubility, solvation, distribution and crystal structure. Int. J. Pharm. 2008, 349, 300–313. [Google Scholar] [CrossRef]
  46. Mora, C.P.; Martínez, F. Thermodynamic quantities relative to solution processes of Naproxen in aqueous media at pH 1.2 and 7.4. Phys. Chem. Liq. 2006, 44, 585–596. [Google Scholar] [CrossRef]
  47. Ryde, U. A fundamental view of enthalpy–entropy compensation. Med. Chem. Commun. 2014, 5, 1324–1336. [Google Scholar] [CrossRef] [Green Version]
  48. Sharp, K. Entropy—Enthalpy compensation: Fact or artifact? Protein Sci. 2001, 10, 661–667. [Google Scholar] [CrossRef]
  49. Chodera, J.D.; Mobley, D.L. Entropy-Enthalpy Compensation: Role and Ramifications in Biomolecular Ligand Recognition and Design. Annu. Rev. Biophys. 2013, 42, 121–142. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Tomlinson, E. Enthalpy-entropy compensation analysis of pharmaceutical, biochemical and biological systems. Int. J. Pharm. 1983, 13, 115–144. [Google Scholar] [CrossRef]
  51. Bustamante, P.; Escalera, B. Enthalpy and Entropy Contributions to the Solubility of Sulphamethoxypyridazine in Solvent Mixtures Showing Two Solubility Maxima. J. Pharm. Pharmacol. 2011, 47, 550–555. [Google Scholar] [CrossRef]
  52. Reillo, A.; Bustamante, P.; Escalera, B.; Jiménez, M.M.; Sellés, E. Solubility Parameter-Based Methods for Predicting the Solubility of Sulfapyridine in Solvent Mixtures. Drug Dev. Ind. Pharm. 1995, 21, 2073–2084. [Google Scholar] [CrossRef]
  53. Beerbower, A.; Wu, P.; Martin, A. Expanded Solubility Parameter Approach I: Naphthalene and Benzoic Acid in Individual Solvents. J. Pharm. Sci. 1984, 73, 179–188. [Google Scholar] [CrossRef]
  54. Zou, Z.; Sun, X.; Yu, Y.; Fang, X.; Xu, L. Determination and correlation of solubility and solution thermodynamics of musk ketone in twelve pure solvents. J. Mol. Liq. 2019, 293, 111437. [Google Scholar] [CrossRef]
  55. Cheng, K.; Wang, L.; Yu, Y.; Xiang, Y.; Bai, W.; Xu, L.; Li, H. Solubility and thermodynamic analysis of 1-(4-tert-butyl-2,6-dimethylphenyl)ethenone in different pure and binary solvents. J. Chem. Thermodyn. 2023, 180, 107019. [Google Scholar] [CrossRef]
  56. Bowden, N.A.; Sevillano, D.M.; Sanders, J.P.; Bruins, M.E. Modelling the effects of ethanol on the solubility of the proteinogenic amino acids with the NRTL, Gude and Jouyban-Acree models. Fluid Phase Equilib. 2018, 459, 158–169. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Molecular structure of sulfamerazine (4-amino-N-(4-methyl-2-pyrimidinyl)).
Figure 1. Molecular structure of sulfamerazine (4-amino-N-(4-methyl-2-pyrimidinyl)).
Sustainability 15 06596 g001
Figure 2. Solubility of sulfamerazine (3) (x3) in MeCN (1) + 1-PrOH (2) cosolvent mixtures vs. mass fraction of MeCN at nine temperatures (◊: 278.15 K; ○: 283.15 K; ∆: 288.15 K; ☐: 293.15 K; ♦: 298.15 K; ■: 303.15 K; ▲: 308.15 K; ●: 313.15 K; and ⋆: 318.15 K).
Figure 2. Solubility of sulfamerazine (3) (x3) in MeCN (1) + 1-PrOH (2) cosolvent mixtures vs. mass fraction of MeCN at nine temperatures (◊: 278.15 K; ○: 283.15 K; ∆: 288.15 K; ☐: 293.15 K; ♦: 298.15 K; ■: 303.15 K; ▲: 308.15 K; ●: 313.15 K; and ⋆: 318.15 K).
Sustainability 15 06596 g002
Figure 3. DSC of the equilibrium solid phase of sulfamerazine (red: n-PrOH; blue: w 1 = 0.50; violet: MeCN; and black: original sample).
Figure 3. DSC of the equilibrium solid phase of sulfamerazine (red: n-PrOH; blue: w 1 = 0.50; violet: MeCN; and black: original sample).
Sustainability 15 06596 g003
Figure 4. van’t Hoff plot of sulfamerazine in {MeCN (1) + 1-PrOH (2)} cosolvent mixtures. (•: n-PrOH; ■: w 1 = 0.10 ; ♦: w 1 = 0.20 ; ⋆: w 1 = 0.30 ; ∆: w 1 = 0.40 ; ◊: w 1 = 0.50 ; ○: w 1 = 0.60 ; +: w 1 = 0.70 ; ☐: w 1 = 0.80 ; ⊕: w 1 = 0.90 ; and ▲: MeCN).
Figure 4. van’t Hoff plot of sulfamerazine in {MeCN (1) + 1-PrOH (2)} cosolvent mixtures. (•: n-PrOH; ■: w 1 = 0.10 ; ♦: w 1 = 0.20 ; ⋆: w 1 = 0.30 ; ∆: w 1 = 0.40 ; ◊: w 1 = 0.50 ; ○: w 1 = 0.60 ; +: w 1 = 0.70 ; ☐: w 1 = 0.80 ; ⊕: w 1 = 0.90 ; and ▲: MeCN).
Sustainability 15 06596 g004
Figure 5. Perlovich’s plot for the solution process of sulfamerazine (3) in cosolvent mixtures {MeCN (1) + 1-PrOH (2)} at T hm = 297.6 K.
Figure 5. Perlovich’s plot for the solution process of sulfamerazine (3) in cosolvent mixtures {MeCN (1) + 1-PrOH (2)} at T hm = 297.6 K.
Sustainability 15 06596 g005
Figure 6. Diagram of hypothetical mixing process (solution formation).
Figure 6. Diagram of hypothetical mixing process (solution formation).
Sustainability 15 06596 g006
Figure 7. Perlovich’s plot, for the transfer process of sulfamerazine (3) in cosolvent mixtures {MeCN (1) + 1-PrOH (2)} at T hm = 297.6 K.
Figure 7. Perlovich’s plot, for the transfer process of sulfamerazine (3) in cosolvent mixtures {MeCN (1) + 1-PrOH (2)} at T hm = 297.6 K.
Sustainability 15 06596 g007
Figure 8. Enthalpy–entropy compensation plot for the solubility of sulfamerazine (3) in {MeCN (1) + 1-PrOH (2)} mixtures at T hm = 297.6 K.
Figure 8. Enthalpy–entropy compensation plot for the solubility of sulfamerazine (3) in {MeCN (1) + 1-PrOH (2)} mixtures at T hm = 297.6 K.
Sustainability 15 06596 g008
Figure 9. Experimental solubility data versus predicted solubility SMR (3) in {MeCN (1) + 1-PrOH (2)} mixtures and cosolvent mixtures (⋆: van’t Hoff; : Yalkowsky–Roseman–van’t Hoff; : Apelblat; ∘: Buchowski–Ksiazczak; : Yaws; : Wilson; ⋄: modified Wilson, and : NRTL).
Figure 9. Experimental solubility data versus predicted solubility SMR (3) in {MeCN (1) + 1-PrOH (2)} mixtures and cosolvent mixtures (⋆: van’t Hoff; : Yalkowsky–Roseman–van’t Hoff; : Apelblat; ∘: Buchowski–Ksiazczak; : Yaws; : Wilson; ⋄: modified Wilson, and : NRTL).
Sustainability 15 06596 g009
Table 1. Trademark and related properties of the reagents used.
Table 1. Trademark and related properties of the reagents used.
Chemical NameCAS aChemical FormulaPurity bAnaly. Tech. c
Sulfamerazine d127-79-7C11H12N4O2S>0.990HPLC
Acetonitrile d75-05-8C2H3N0.998GC
1-PrOH d71-23-8C3H8O0.998GC
Sodium hydroxide d1310-73-2NaOH≥97.0
a Chemical Abstracts Service Registry Number; b in-mass fraction; c HPLC is high-performance liquid chromatography, and GC is gas chromatography. d Source: Sigma-Aldrich, Burlington, MA, USA.
Table 2. Experimental solubility of sulfamerazine (3) in {acetoitrile (1) + 1-PrOH (2)} cosolvent mixtures expressed in mole fraction (104x3) at different temperatures and p = 96 kPa ac.
Table 2. Experimental solubility of sulfamerazine (3) in {acetoitrile (1) + 1-PrOH (2)} cosolvent mixtures expressed in mole fraction (104x3) at different temperatures and p = 96 kPa ac.
w1 bTemperatures
278.15 K283.15 K288.15 K293.15 K298.15 K303.15 K308.15 K313.15 K318.15 K
0.000.9111.1481.4351.7792.1482.6473.0743.7554.511
0.051.0361.3111.6291.9432.4252.9633.4934.2615.084
0.101.1851.4891.8442.1982.7273.3323.9364.8095.785
0.151.3541.6942.0902.4853.0703.7424.4465.4366.564
0.201.5461.9282.3682.8103.4564.2035.0206.1437.45
0.251.7642.1962.6853.1783.8944.7155.6816.9528.434
0.302.0222.4963.0433.5964.3815.3136.4007.8469.625
0.352.3112.8253.4304.0604.9115.9687.1768.82110.95
0.402.6463.2213.8984.5975.5366.7198.1179.98512.46
0.453.0073.6724.4175.1946.2417.5139.20611.3114.03
0.503.4644.1915.0375.8947.0468.50310.4212.8216.10
0.553.9624.7155.6606.6207.9079.45311.7114.4318.23
0.604.5215.3716.4127.4958.89210.6413.2116.2920.70
0.655.1686.1077.2648.47210.0111.9514.9118.4123.50
0.705.9066.9458.2299.57811.2713.4216.8420.8026.69
0.756.7597.8879.32310.8212.6915.0319.0423.5230.30
0.807.7149.00210.5712.2714.2916.9721.4726.5934.43
0.858.77010.2411.9613.8716.0019.1024.1229.8939.03
0.9010.0411.6813.5615.7218.0721.5127.2733.8744.37
0.9511.5013.2115.3517.6920.3423.9730.8738.2850.33
1.0013.0915.1017.4020.0922.8627.1434.7343.1957.18
a is the atmospheric pressure in Neiva, Colombia, b is the mass fraction of MeCN (1) in the {acetoitrile (1) + 1-PrOH (2)} mixtures free of sulfamerazine (3), c is standard uncertainty in p is u ( p ) = 3.0 kPa. Average relative standard uncertainty in w 1 is u r ( w 1 ) = 0.0008 . Standard uncertainty in T is u ( T ) = 0.10 K. Average relative standard uncertainty in x 3 is u r ( x 3 ( 1 + 2 ) ) = 0.025 .
Table 3. Thermophysical properties of SMR obtained by the DSC.
Table 3. Thermophysical properties of SMR obtained by the DSC.
SampleEnthalpy of Melting, Δ m H /kJ·mol−1Melting Point T m /K
Original sample a41.3 ± 0.5508.5 ± 0.5
31.6 b515.2 b
24.75 c509.3–510.3 c
41.3 d508.5 d
41.3 ± 1.0 e508.5 e
508.9 f
506.4 g
508.95 h
510.66 i
508.5 j
508.5 k
1-PrOH41.2 ± 0.5508.4 ± 0.5
w 0.50 41.31 ± 0.5510.2 ± 0.5
Acetonitrile40.9 ± 0.5509.1 ± 0.5
a High -purity commercial standard; b Sunwoo and Eisen [36]; c Lee et al. [37]; d Martínez and Gómez [38]; e Delgado and Martínez [16]; f Blanco et al. [12]; g Khattab [39]; h Delombaerde [40]; i Aloisio et al. [41]; j Cardenas et al. [11]; k Vargas et al. [18].
Table 4. Thermodynamic functions of sulfamerazine solution process (3) in {acetonitrile (1) + water (2)} cosolvent mixtures at T h m = 297.6 K a.
Table 4. Thermodynamic functions of sulfamerazine solution process (3) in {acetonitrile (1) + water (2)} cosolvent mixtures at T h m = 297.6 K a.
w 1 b Δ soln G ° /
(kJ·mol−1)
Δ soln H °
(kJ·mol−1)
Δ soln S °
(J·mol−1·K−1)
T hm Δ soln S °
(kJ·mol−1)
ζ H  c ζ TS  c
0.0020.9629.2527.858.290.7790.221
0.0520.6629.0928.338.430.7750.225
0.1020.3528.9428.868.590.7710.229
0.1520.0428.7829.378.740.7670.233
0.2019.7428.6329.888.890.7630.237
0.2519.4328.4730.389.040.7590.241
0.3019.1228.3230.929.200.7550.245
0.3518.8228.1831.439.350.7510.249
0.4018.5128.0231.969.510.7470.253
0.4518.2127.8632.449.650.7430.257
0.5017.8927.7133.019.820.7380.262
0.5517.5927.5833.559.990.7340.266
0.6017.2927.4234.0510.130.7300.270
0.6516.9827.2734.5710.290.7260.274
0.7016.6727.1235.0910.440.7220.278
0.7516.3726.9735.6210.60.7180.282
0.8016.0626.8136.1310.750.7140.286
0.8515.7626.6436.5610.880.7100.290
0.9015.4526.4937.1111.040.7060.294
0.9515.1426.3537.6511.20.7020.298
1.014.8326.1838.1311.350.6980.302
a Average relative standard uncertainty in w 1 is u r ( w 1 ) = 0.0008 . Standard uncertainty in T is u ( T ) = 0.10 K. Average relative standard uncertainties in apparent thermodynamic quantities of real dissolution processes are u r ( Δ soln G ° ) = 0.015 , u r ( Δ soln H ° ) = 0.019 , u r ( Δ soln S ° ) = 0.024, and u r ( T Δ soln S ° ) = 0.024. b w 1 is the mass fraction of acetonitrile (1) in the {acetonitrile (1) + 1-propanol (2)} mixtures free of sulfadiazine (3). c ζ H and ζ T S are the relative contributions by enthalpy and entropy toward the apparent Gibbs energy of dissolution.
Table 5. Thermodynamic functions relative to mixing processes of sulfadiazine (3) in {acetonitrile (1) + 1-propanol (2)} co-solvent mixtures at T hm = 297.6 K a.
Table 5. Thermodynamic functions relative to mixing processes of sulfadiazine (3) in {acetonitrile (1) + 1-propanol (2)} co-solvent mixtures at T hm = 297.6 K a.
w 1 b Δ mix G °
(kJ·mol−1)
Δ mix H °
(kJ·mol−1)
Δ mix S °
(J·mol−1·K−1)
T Δ mix S °
(kJ·mol−1)
0.00−3.7305.10729.6968.837
0.05−4.0384.94430.1808.981
0.10−4.3444.79330.7039.137
0.15−4.6504.63931.2149.289
0.20−4.9574.48531.7269.441
0.25−5.2644.32732.2279.590
0.30−5.5724.17832.7659.750
0.35−5.8724.03233.2809.904
0.40−6.1843.87833.80910.061
0.45−6.4883.71534.28410.203
0.50−6.8073.56534.85610.373
0.55−7.1003.43435.40110.535
0.60−7.4073.27635.89810.683
0.65−7.7143.12436.41710.837
0.70−8.0202.97136.93310.991
0.75−8.3262.82437.46811.150
0.80−8.6362.66437.97211.300
0.85−8.9372.49438.41011.430
0.90−9.2482.34538.95711.593
0.95−9.5512.20339.49811.754
1.00−9.8602.03639.97311.896
a Average relative standard uncertainty in w 1 is u r ( w 1 ) = 0.0008. Standard uncertainty in T is u ( T ) = 0.10 K. Average relative standard uncertainties in apparent thermodynamic quantities of real dissolution processes are u r ( Δ mix G ° ) = 0.015, u r ( Δ mix H ° ) = 0.019, u r ( Δ mix S ° ) = 0.024, and u r ( T Δ mix S ° )= 0.024. b w 1 is the mass fraction of acetonitrile (1) in the {acetonitrile (1) + water (2)} mixtures free of sulfamerazine (3).
Table 6. Statistical analysis of the models correlation.
Table 6. Statistical analysis of the models correlation.
ModelCorrelation CoefficientFF Criticp
van’t Hoff0.9874727.91.33 × 10 100 ≪0.001
Yalkowsky–Roseman–van’t Hoff0.99414,801.75.63 × 10 180 ≪0.001
Apelblat0.9959753.95.08 × 10 87 ≪0.001
Buchowski–Ksiazczak0.99823,781.18.39 × 10 103 ≪0.001
Yaws0.999100,234.72.25 × 10 128 ≪0.001
NRTL1.000438,496.58.73 × 10 208 ≪0.001
Wilson1.0006,076,060.49.01 × 10 195 ≪0.001
modified Wilson1.00016,746,788.29.65 × 10 299 ≪0.001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ortiz, C.P.; Cardenas-Torres, R.E.; Herrera, M.; Delgado, D.R. Numerical Analysis of Sulfamerazine Solubility in Acetonitrile + 1-Propanol Cosolvent Mixtures at Different Temperatures. Sustainability 2023, 15, 6596. https://doi.org/10.3390/su15086596

AMA Style

Ortiz CP, Cardenas-Torres RE, Herrera M, Delgado DR. Numerical Analysis of Sulfamerazine Solubility in Acetonitrile + 1-Propanol Cosolvent Mixtures at Different Temperatures. Sustainability. 2023; 15(8):6596. https://doi.org/10.3390/su15086596

Chicago/Turabian Style

Ortiz, Claudia Patricia, Rossember Edén Cardenas-Torres, Mauricio Herrera, and Daniel Ricardo Delgado. 2023. "Numerical Analysis of Sulfamerazine Solubility in Acetonitrile + 1-Propanol Cosolvent Mixtures at Different Temperatures" Sustainability 15, no. 8: 6596. https://doi.org/10.3390/su15086596

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop